These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35051043)

  • 1. HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity.
    Ghosh S; De Smedt J; Tricot T; Proença S; Kumar M; Nami F; Vanwelden T; Vidal N; Jennings P; Kramer NI; Verfaillie CM
    Toxics; 2021 Dec; 10(1):. PubMed ID: 35051043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells.
    Gao X; Li R; Sprando RL; Yourick JJ
    Cell Biol Toxicol; 2021 Apr; 37(2):245-259. PubMed ID: 32447489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes.
    Ter Braak B; Niemeijer M; Boon R; Parmentier C; Baze A; Richert L; Huppelschoten S; Wink S; Verfaillie C; van de Water B
    Toxicol In Vitro; 2021 Jun; 73():105107. PubMed ID: 33545341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
    Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
    Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical, functional and transcriptomic comparison of two modified methods of hepatocyte differentiation from human induced pluripotent stem cells.
    Li R; Zhao Y; Yourick JJ; Sprando RL; Gao X
    Biomed Rep; 2022 May; 16(5):43. PubMed ID: 35371477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 8. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
    Yu Y; Liu H; Ikeda Y; Amiot BP; Rinaldo P; Duncan SA; Nyberg SL
    Stem Cell Res; 2012 Nov; 9(3):196-207. PubMed ID: 22885101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene.
    Nagamoto Y; Takayama K; Tashiro K; Tateno C; Sakurai F; Tachibana M; Kawabata K; Ikeda K; Tanaka Y; Mizuguchi H
    Cell Transplant; 2015; 24(6):1127-38. PubMed ID: 24806294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.
    Asgari S; Moslem M; Bagheri-Lankarani K; Pournasr B; Miryounesi M; Baharvand H
    Stem Cell Rev Rep; 2013 Aug; 9(4):493-504. PubMed ID: 22076752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
    Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
    Sci Rep; 2017 Jan; 7():41238. PubMed ID: 28120901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
    Jozefczuk J; Prigione A; Chavez L; Adjaye J
    Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
    Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
    PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
    Mitani S
    Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
    Cao YY; Zeng X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.